These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19419819

  • 1. Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results.
    Ishikawa H, Nonaka T, Sakurai H, Tamaki Y, Kitamoto Y, Ebara T, Shioya M, Noda SE, Shirai K, Suzuki Y, Takahashi T, Nakano T.
    Int J Radiat Oncol Biol Phys; 2010 Feb 01; 76(2):452-9. PubMed ID: 19419819
    [Abstract] [Full Text] [Related]

  • 2. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma.
    Nishimura Y, Okuno Y, Ono K, Mitsumori M, Nagata Y, Hiraoka M.
    Cancer; 1999 Jul 15; 86(2):220-8. PubMed ID: 10421257
    [Abstract] [Full Text] [Related]

  • 3. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
    Tamaki T, Ishikawa H, Takahashi T, Tamaki Y, Kitamoto Y, Okamoto M, Noda SE, Katoh H, Shirai K, Sakurai H, Nakano T.
    Brachytherapy; 2012 Jul 15; 11(2):130-6. PubMed ID: 21700506
    [Abstract] [Full Text] [Related]

  • 4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 6. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E, Dar R, Rodrigues GB, Stitt L, Videtic GM, Truong P, Tomiak A, Ash R, Brecevic E, Inculet R, Malthaner R, Vincent M, Craig I, Kocha W, Lefcoe M.
    Radiother Oncol; 2004 Nov 01; 73(2):141-8. PubMed ID: 15542160
    [Abstract] [Full Text] [Related]

  • 7. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
    Ishikawa H, Sakurai H, Tamaki Y, Nonaka T, Yamakawa M, Saito Y, Kitamoto Y, Higuchi K, Hasegawa M, Nakano T.
    J Gastroenterol Hepatol; 2006 Aug 01; 21(8):1290-6. PubMed ID: 16872312
    [Abstract] [Full Text] [Related]

  • 8. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
    Sur R, Donde B, Falkson C, Ahmed SN, Levin V, Nag S, Wong R, Jones G.
    Brachytherapy; 2004 Aug 01; 3(4):191-5. PubMed ID: 15607150
    [Abstract] [Full Text] [Related]

  • 9. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP.
    Brachytherapy; 2006 Aug 01; 5(4):218-22. PubMed ID: 17118313
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of definitive radiotherapy for stage I esophageal cancer.
    Sai H, Mitsumori M, Araki N, Mizowaki T, Nagata Y, Nishimura Y, Hiraoka M.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1339-44. PubMed ID: 16029790
    [Abstract] [Full Text] [Related]

  • 12. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V, Geiger M, Lotter M, Sauer R.
    Brachytherapy; 2003 Aug 01; 2(3):158-63. PubMed ID: 15062138
    [Abstract] [Full Text] [Related]

  • 13. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA, Demanes DJ, Galalae R, Vargas C, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1322-31. PubMed ID: 16029788
    [Abstract] [Full Text] [Related]

  • 14. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A, Lin K, Tiong CE, Tan LK, Loh TK, Goh BC, Lu JJ.
    Laryngoscope; 2006 Jun 01; 116(6):938-43. PubMed ID: 16735885
    [Abstract] [Full Text] [Related]

  • 15. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):684-90. PubMed ID: 15183471
    [Abstract] [Full Text] [Related]

  • 16. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ, Brandt D, Schour L, Hill DR.
    Am J Clin Oncol; 2009 Aug 01; 32(4):342-7. PubMed ID: 19398902
    [Abstract] [Full Text] [Related]

  • 17. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
    Vuong T, Szego P, David M, Evans M, Parent J, Mayrand S, Corns R, Burtin P, Faria S, Devic S.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):758-64. PubMed ID: 16199311
    [Abstract] [Full Text] [Related]

  • 18. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M.
    Cancer; 2000 Mar 01; 88(5):988-95. PubMed ID: 10699886
    [Abstract] [Full Text] [Related]

  • 19. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.
    Pai HH, Souhami L, Clark BG, Roman T.
    Gynecol Oncol; 1997 Aug 01; 66(2):300-7. PubMed ID: 9264580
    [Abstract] [Full Text] [Related]

  • 20. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
    Nag S, Martínez-Monge R, Copeland LJ, Vacarello L, Lewandowski GS.
    Gynecol Oncol; 1997 Jul 01; 66(1):16-9. PubMed ID: 9234914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.